Search research articles
Contact Us
Filters
Showing results (1-10 of 352) with videos related to
Page
of 36
Sort By:
Digestive Diseases (Basel, Switzerland)
|
February 2, 2017
Fecal Microbiota Transplantation in Inflammatory Bowel Disease
Walter Reinisch
Current Drug Targets
|
March 10, 2010
"How to manage loss of response to anti-TNF in Crohn's disease? "
Walter Reinisch
The American Journal of Gastroenterology
|
June 9, 2015
Serial Fecal Calprotectin and Lactoferrin Measurements for Early Diagnosis of Pouchitis After Proctocolectomy for Ulcerative Colitis: Is Pouchoscopy No Longer Needed?
Alain Schoepfer, Walter Reinisch
Best Practice & Research. Clinical Gastroenterology
|
June 18, 2013
Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases?
David Berry, Walter Reinisch
Gut
|
September 4, 2012
Interleukin 13 and its role in gut defence and inflammation
Peter Mannon, Walter Reinisch
The American Journal of Gastroenterology
|
July 4, 2014
Thiopurines and the natural course of Crohn's disease: did we finally find the right therapeutic target?
Florian Rieder, Walter Reinisch
Seminars in Arthritis and Rheumatism
|
June 11, 2015
Biosimilar safety factors in clinical practice
Walter Reinisch, Josef Smolen
Journal of Crohn'S & Colitis
|
September 2, 2025
Modulating checkpoint molecules in inflammatory bowel diseases as a new therapeutic strategy: a narrative review
Zlata Chkolnaia, Walter Reinisch, Mathieu Uzzan
Current Opinion in Gastroenterology
|
May 25, 2013
Drug monitoring of biologics in inflammatory bowel disease
Alexander Eser, Christian Primas, Walter Reinisch
Expert Review of Gastroenterology & Hepatology
|
September 24, 2015
The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13
Walter Reinisch, Edouard Louis, Silvio Danese
Page
of 36
Search research articles
Search
Showing results (1-10 of 352) with videos related to
Sort By:
Page
of 36
Digestive Diseases (Basel, Switzerland)
|
February 2, 2017
Fecal Microbiota Transplantation in Inflammatory Bowel Disease
Walter Reinisch
Current Drug Targets
|
March 10, 2010
"How to manage loss of response to anti-TNF in Crohn's disease? "
Walter Reinisch
The American Journal of Gastroenterology
|
June 9, 2015
Serial Fecal Calprotectin and Lactoferrin Measurements for Early Diagnosis of Pouchitis After Proctocolectomy for Ulcerative Colitis: Is Pouchoscopy No Longer Needed?
Alain Schoepfer, Walter Reinisch
Best Practice & Research. Clinical Gastroenterology
|
June 18, 2013
Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases?
David Berry, Walter Reinisch
Gut
|
September 4, 2012
Interleukin 13 and its role in gut defence and inflammation
Peter Mannon, Walter Reinisch
The American Journal of Gastroenterology
|
July 4, 2014
Thiopurines and the natural course of Crohn's disease: did we finally find the right therapeutic target?
Florian Rieder, Walter Reinisch
Seminars in Arthritis and Rheumatism
|
June 11, 2015
Biosimilar safety factors in clinical practice
Walter Reinisch, Josef Smolen
Journal of Crohn'S & Colitis
|
September 2, 2025
Modulating checkpoint molecules in inflammatory bowel diseases as a new therapeutic strategy: a narrative review
Zlata Chkolnaia, Walter Reinisch, Mathieu Uzzan
Current Opinion in Gastroenterology
|
May 25, 2013
Drug monitoring of biologics in inflammatory bowel disease
Alexander Eser, Christian Primas, Walter Reinisch
Expert Review of Gastroenterology & Hepatology
|
September 24, 2015
The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13
Walter Reinisch, Edouard Louis, Silvio Danese
Page
of 36